Oxford Biomedica Solutions
Kalyani N. is a highly experienced Senior Research Associate currently employed at Oxford Biomedica since January 2023, previously holding a similar position at Oxford Biomedica Solutions from March 2022 to December 2022. Prior to these roles, Kalyani worked at Homology Medicines, Inc. from July 2020 to March 2022, where progression included titles from Research Associate I to Senior Research Associate I. Academic background includes a Master of Science in Pharmacology from the Massachusetts College of Pharmacy and Health Sciences, where Kalyani also served as a Graduate Teaching Assistant and contributed significantly to undergraduate courses. A thorough understanding of laboratory protocols and regulatory compliance was developed during internships at Kentner Laboratory and Pfizer. Research experience is complemented by a bachelor's degree in Pharmacy from Shreemati Nathibai Damodar Thackersey Women's University, showcasing a strong foundation in the pharmaceutical sciences.
This person is not in the org chart
Oxford Biomedica Solutions
Oxford Biomedica Solutions, LLC is the high-performing, full scope Adeno-Associated Virus (AAV) vector Manufacturing and Innovation joint venture of Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group”), and Homology Medicines, Inc. (Nasdaq: FIXX) (“Homology”). We offer global pharmaceutical and biotechnology clients innovative manufacturing expertise in AAV and lentiviral-based cell and gene therapies. Oxford Biomedica Solutions LLC provides access to Homology’s innovative and proven end-to-end AAV manufacturing capabilities, and customers also benefit from technical synergies brought in by the Group’s know-how in lentiviral vector manufacturing. This collaborative and complementary vector-based approach has the potential to accelerate our collective mission to improve patients’ lives worldwide.